Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Short-term Effects of Passiflora and Meditation on Blood Pressure and Heart Rate

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03953469
Recruitment Status : Not yet recruiting
First Posted : May 16, 2019
Last Update Posted : March 26, 2020
Sponsor:
Information provided by (Responsible Party):
Kimberly Sanders, University of Bridgeport

Brief Summary:
This study is intended to study the effects of one-time acute dosing of a solid extract of Passiflora incarnata, also known as Passionflower, on blood pressure and heart rate in students. Our hypothesis is that blood pressure levels and heart rates will decrease significantly in response to Passiflora incarnata.

Condition or disease Intervention/treatment Phase
Heart Rate Fast Blood Pressure Dietary Supplement: Passiflora incarnata Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 250 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Triple (Participant, Investigator, Outcomes Assessor)
Masking Description: There are two arms. One arm involves consuming a placebo. The second arm involves taking the Passionflower. Neither the primary investigator nor the participant will know which treatment they are taking.
Primary Purpose: Treatment
Official Title: Investigating the Short-term Effects of Passiflora Incarnate and Mobile Audio-guided Meditation on Blood Pressure and Heart Rate in Naturopathic Medical Students
Estimated Study Start Date : August 2020
Estimated Primary Completion Date : May 2021
Estimated Study Completion Date : August 2021

Resource links provided by the National Library of Medicine

Drug Information available for: Passiflora

Arm Intervention/treatment
No Intervention: Placebo Group

(a) Baseline blood pressure readings and one heart rate reading taken after at least 5 minutes of rest time without talking, eating, or caffeine consumption.

b) will be given 1/4 tsp of blackstrap molasses placebo. Subjects may not consume caffeine or eat food during this time.

(c) blood pressure readings and one heart rate will be taken 15 minutes after the baseline reading.

Active Comparator: Group II
  1. Baseline blood pressure readings and one heart rate reading taken after at least 5 minutes of rest time without talking, eating food, or caffeine consumption.
  2. 15 minutes after examination - will be given 1/8 tsp (900mg) of Passiflora incarnata solid extract by Wise Woman Herbals mixed with 1/8 tsp of blackstrap molasses to mask the taste.
  3. blood pressure readings and one heart rate will be taken 15 minutes after the baseline reading.
Dietary Supplement: Passiflora incarnata
One-time administration of 1/8 tsp solid extract Passiflora incarnata providing 900mg of Passiflora incarnata
Other Name: Passionflower




Primary Outcome Measures :
  1. Change in blood pressure between baseline and 15 minutes [ Time Frame: 15 minutes ]
    Change in blood pressure between baseline and 15 minutes

  2. Change in heart rate between baseline and 15 minutes [ Time Frame: 15 minutes ]
    Change in heart rate between baseline and 15 minutes



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria: all University of Bridgeport students are invited to participate

Exclusion Criteria:

  1. Those taking hypertensive medication
  2. Those taking anti-anxiety medication, including MAOI medication
  3. Those taking blood-thinning medication
  4. Those who are pregnant
  5. Those who could be pregnant
  6. Those who will have surgery 2 weeks before the research date
  7. Those who are scheduled to have surgery 2 weeks after the research date
  8. Those who have consumed caffeine, food/tyramine containing foods, stimulant medication, cold medicine, decongestant medicine, antihistamine medicine, cough suppressants, alcoholic beverages, or stimulant energy drinks within 2 hours before the study period.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03953469


Contacts
Layout table for location contacts
Contact: Kimberly Sanders, ND 2035764425 kimbersa@bridgeport.edu
Contact: Mark Mattie, MD, PhD mmattie@bridgeport.edu

Sponsors and Collaborators
University of Bridgeport
Investigators
Layout table for investigator information
Principal Investigator: Kimberly Sanders, ND University of Bridgeport
  Study Documents (Full-Text)

Documents provided by Kimberly Sanders, University of Bridgeport:
Study Protocol  [PDF] March 28, 2019
Informed Consent Form  [PDF] March 28, 2019

Layout table for additonal information
Responsible Party: Kimberly Sanders, Principal Investigator, Assistant Professor of Clinical Sciences, University of Bridgeport
ClinicalTrials.gov Identifier: NCT03953469    
Other Study ID Numbers: 2019-02-01
First Posted: May 16, 2019    Key Record Dates
Last Update Posted: March 26, 2020
Last Verified: March 2020
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Kimberly Sanders, University of Bridgeport:
passionflower
heart rate
blood pressure
Additional relevant MeSH terms:
Layout table for MeSH terms
Tachycardia
Arrhythmias, Cardiac
Heart Diseases
Cardiovascular Diseases
Cardiac Conduction System Disease
Pathologic Processes